专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US09721399B2 Vehicle diagnosing apparatus, vehicle diagnosing system, and diagnosing method 有权
公开(公告)号：US09721399B2
公开(公告)日：2017-08-01
申请号：US12368885
申请日：2009-02-10
申请人： Tomoyasu Ishikawa
发明人： Tomoyasu Ishikawa
IPC分类号： G07C5/08 , G07C5/00
CPC分类号： G07C5/0808 , G07C5/008
摘要： A vehicle diagnosing apparatus, a vehicle diagnosing system, and a diagnosing method enable the determination of completion of a repair or part replacement on a vehicle while adapting to changes in environment and overcoming temporal or spatial restrictions. The vehicle diagnosing apparatus reads diagnostic information from an on-board diagnosing unit on the vehicle that detects an abnormality in an on-board device. A result of a maintenance work performed on the on-board device is finalized by a maintenance result finalizing unit. A determination unit determines the appropriateness of the finalized maintenance work result with reference to determination information stored in a database that is continuously updated. The result of the determination is indicated by a notifying unit. Analogy is used to obtain the diagnostic information when the on-board device requires a long time or a certain condition to provide accurate diagnostic information.

2. 发明申请

US20070021479A1 Phorboxazole compounds and methods of their preparation 有权
标题翻译： Phorboxazole化合物及其制备方法
公开(公告)号：US20070021479A1
公开(公告)日：2007-01-25
申请号：US11408573
申请日：2006-04-20
申请人： Thomas Razler , Amos Smith , Jeffrey Ciavarri , Tomoyasu Hirose , Tomoyasu Ishikawa
发明人： Thomas Razler , Amos Smith , Jeffrey Ciavarri , Tomoyasu Hirose , Tomoyasu Ishikawa
IPC分类号： A61K31/424 , C07D491/22
CPC分类号： C07D498/22
摘要： Novel macrolactone compounds, their methods of preparation, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the macrolactone compounds may be useful, inter alia, for treating various cancers, inducing apoptosis in malignant cells, or inhibiting cancer cell division.
摘要翻译：公开了新型的大分子内酯，其制备方法，含有这些化合物的药物组合物及其制药方法。在某些实施方案中，大分子内酯化合物尤其可用于治疗各种癌症，诱导恶性细胞凋亡或抑制癌细胞分裂。

3. 发明授权

US06906055B2 Phosphonocephem compound 有权
标题翻译：膦酰基化合物
公开(公告)号：US06906055B2
公开(公告)日：2005-06-14
申请号：US10343285
申请日：2001-08-10
申请人： Tomoyasu Ishikawa , Shohei Hashiguchi , Yuji Iizawa
发明人： Tomoyasu Ishikawa , Shohei Hashiguchi , Yuji Iizawa
IPC分类号： A61K31/675 , A61P31/04 , C07D501/14 , C07F9/6561 , C07D501/59 , A61K31/546
CPC分类号： A61K31/675 , C07F9/65613
摘要： A cephem compound (particularly its crystal) represented by the formula [I], wherein X is CH3COOH, CH3CH2COOH or CH3CN, and n is 0 to 5, is useful as an antibacterial agent (particularly anti-MRSA agent) and shows superior quality such as high solid stability, possible long-term stable preservation and the like.
摘要翻译：由式[I]表示的头孢烯化合物（特别是其结晶），其中X是CH 3 COOH，CH 3 CH 2 COOH或 CH 3 CN，n为0〜5，可用作抗菌剂（特别是抗MRSA剂），并且具有优异的质量，例如高固体稳定性，可能的长期稳定保存等。

4. 发明授权

US08791803B2 Abnormality detection apparatus 有权
标题翻译：异常检测装置
公开(公告)号：US08791803B2
公开(公告)日：2014-07-29
申请号：US13112248
申请日：2011-05-20
申请人： Tomoyasu Ishikawa
发明人： Tomoyasu Ishikawa
IPC分类号： B60Q1/00
CPC分类号： G01M15/042 , G07C5/0816
摘要： An abnormality detection apparatus has: an abnormality detection portion that detects at least one of an abnormality of a vehicle and an abnormality of an in-vehicle device based on an output of the in-vehicle device that indicates a state of a vehicle; an environmental drive condition information obtaining portion that obtains information regarding an environmental drive condition that affects the output of the in-vehicle device; and an abnormality detection criteria changing portion that changes an abnormality detection criteria used by the abnormality detecting portion based on the environmental drive condition information obtained by the environmental drive condition information obtaining portion.
摘要翻译：异常检测装置具有：异常检测部，其基于表示车辆的状态的车载装置的输出，检测车辆的异常和车内装置的异常中的至少一个; 获取关于影响车载装置的输出的环境驱动条件的信息的环境驱动条件信息获取部; 以及异常检测基准变更部，其根据由环境驱动条件信息获取部获得的环境驱动条件信息，改变异常检测部所使用的异常检测标准。

5. 发明申请

US20100250061A1 VEHICLE CONTROL DEVICE 审中-公开
标题翻译：车辆控制装置
公开(公告)号：US20100250061A1
公开(公告)日：2010-09-30
申请号：US12741999
申请日：2009-01-15
申请人： Naoki Toyofuku , Tomoyasu Ishikawa
发明人： Naoki Toyofuku , Tomoyasu Ishikawa
IPC分类号： G06F7/00
CPC分类号： G07C5/085
摘要： A vehicle control device includes a control unit controlling an in-vehicle device and a status information acquisition unit acquiring status information of a vehicle and output the acquired status information to the control unit. In the vehicle control device, the control unit specifies a failure-cause-verification information to be used for verifying a cause of a failure from among the status information acquired by the status information acquisition unit, the failure-cause-verification information being specified by using a timing when a predetermined fail-safe control is started as a reference, the timing being determined based on the status information acquired by the status information acquisition unit, and the control unit stores the specified failure-cause-verification information in a predetermined storage medium.
摘要翻译：车辆控制装置包括控制车内装置的控制单元和获取车辆的状态信息的状态信息获取单元，并将所获取的状态信息输出到控制单元。在车辆控制装置中，控制单元从由状态信息获取单元获取的状态信息中指定用于验证故障原因的故障原因验证信息，故障原因验证信息由当以预定的故障安全控制开始作为参考的定时时，基于由状态信息获取单元获取的状态信息来确定定时，并且控制单元将指定的故障原因验证信息存储在预定存储器中。

6. 发明申请

US20090233937A1 FUSED HETEROCYCLIC COMPOUND 审中-公开
标题翻译：熔融杂环化合物
公开(公告)号：US20090233937A1
公开(公告)日：2009-09-17
申请号：US12402259
申请日：2009-03-11
申请人： Tomoyasu ISHIKAWA , Youichi KAWAKITA
发明人： Tomoyasu ISHIKAWA , Youichi KAWAKITA
IPC分类号： A61K31/4985 , C07D487/02 , A61K31/519 , C07D487/12 , A61P35/00
CPC分类号： C07D487/04
摘要： The present invention provides a fused heterocyclic compound having a tyrosine kinase inhibitory action, which is represented by the formula: wherein ring A is an optionally substituted benzene ring; ring B is an optionally substituted benzoisothiazole ring; R1 is a hydrogen atom, a halogen atom, or an optionally substituted group bonded via a carbon atom, a nitrogen atom or an oxygen atom; R2 is a hydrogen atom, or an optionally substituted group bonded via a carbon atom or a sulfur atom; R3 is a hydrogen atom or an optionally substituted aliphatic hydrocarbon group; or R1 and R2, or R2 and R3 are optionally bonded to each other to form an optionally substituted ring structure; or R3 is optionally bonded to the carbon atom on ring A to form an optionally substituted ring structure; or a salt thereof.
摘要翻译：本发明提供具有酪氨酸激酶抑制作用的稠合杂环化合物，其由下式表示：其中环A是任选取代的苯环; 环B是任选取代的苯并异噻唑环; R1是通过碳原子，氮原子或氧原子键合的氢原子，卤素原子或任选取代的基团; R2是氢原子，或通过碳原子或硫原子键合的任意取代的基团; R3是氢原子或任选取代的脂族烃基; 或R 1和R 2，或者R 2和R 3可任选地彼此键合以形成任选取代的环结构; 或R3任选地键合到环A上的碳原子上以形成任选取代的环结构; 或其盐。

7. 发明申请

US20090163563A1 Phorboxazole Compounds and Methods of Their Preparation 审中-公开
标题翻译： Phorboxazole化合物及其制备方法
公开(公告)号：US20090163563A1
公开(公告)日：2009-06-25
申请号：US12325706
申请日：2008-12-01
申请人： Thomas M. Razler , Amos B. Smith, III , Jeffrey P. Ciavarri , Tomoyasu Hirose , Tomoyasu Ishikawa
发明人： Thomas M. Razler , Amos B. Smith, III , Jeffrey P. Ciavarri , Tomoyasu Hirose , Tomoyasu Ishikawa
IPC分类号： A61K31/424 , C07D498/22 , C12N5/02
CPC分类号： C07D498/22
摘要： Novel macrolactone compounds, their methods of preparation, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the macrolactone compounds may be useful, inter alia, for treating various cancers, inducing apoptosis in malignant cells, or inhibiting cancer cell division.
摘要翻译：公开了新型的大分子内酯，其制备方法，含有这些化合物的药物组合物及其制药方法。在某些实施方案中，大分子内酯化合物尤其可用于治疗各种癌症，诱导恶性细胞凋亡或抑制癌细胞分裂。

8. 发明申请

US20120299556A1 DETERIORATION DEGREE DETERMINING APPARATUS 审中-公开
标题翻译：测定方法测定装置
公开(公告)号：US20120299556A1
公开(公告)日：2012-11-29
申请号：US13495040
申请日：2012-06-13
申请人： Tomoyasu ISHIKAWA , Keiichi Tanaka
发明人： Tomoyasu ISHIKAWA , Keiichi Tanaka
IPC分类号： H02J7/14
CPC分类号： B60R16/0232 , B60L1/06 , B60L3/0046 , B60L50/50 , B60L58/16 , G01R31/392 , Y02T10/7005 , Y02T10/705
摘要： A deterioration degree determining apparatus determines a deterioration degree of a battery of a vehicle. The device includes an electric component activating part activating a non-driving series electric component of the vehicle by using electric power of the battery to determine the deterioration degree of the battery, a charge degree obtaining part which obtains a charge degree of the battery during a time period in which a charge state of the battery is increased to a designated degree by charging the battery after the battery is discharged for a designated period of time by causing the electric component activating part to activate the non-driving series electric component, the battery being charged by electric power generated by an electric generator of the vehicle; and a deterioration degree determining part determining the deterioration degree of the battery based on the charge degree obtained by the charge degree obtaining part.
摘要翻译：劣化度判定装置判定车辆的电池的劣化程度。该装置包括通过使用电池的电力来激活车辆的非驱动串联电气部件以确定电池的劣化程度的电气部件启动部件，在充电度获得部件中获得电池的充电度电池的充电状态通过使电气部件启动部分激活非驱动串联电气部件而在电池放电指定的时间段之后对电池充电而将电池的充电状态增加到指定的时间段，电池由车辆的发电机产生的电力进行充电; 以及劣化度确定部，基于由所述充电度获得部获得的充电度来确定所述电池的劣化程度。

9. 发明申请

US20110029186A1 FAILURE DIAGNOSTIC INFORMATION GENERATING APPARATUS AND FAILURE DIAGNOSTIC INFORMATION GENERATING SYSTEM 审中-公开
标题翻译：故障诊断信息生成装置和故障诊断信息生成系统
公开(公告)号：US20110029186A1
公开(公告)日：2011-02-03
申请号：US12935997
申请日：2009-04-02
申请人： Tomoyasu Ishikawa
发明人： Tomoyasu Ishikawa
IPC分类号： G06F7/00
CPC分类号： G07C5/0808
摘要： A failure diagnostic information generating apparatus includes a repair information acquiring unit that acquires repair information indicating the content of repair or replacement conducted for a vehicle malfunction or a cause of the malfunction; an malfunction-time vehicle information acquiring unit that acquires malfunction-time vehicle information indicating a vehicle state detected when the malfunction occurs; an instruction information generating unit that generates instruction information, usable for future repair or replacement, on the basis of the repair information and the malfunction-time vehicle information; and a recurrence information acquiring unit that acquires recurrence information indicating whether the malfunction has recurred after the repair or replacement. It is determined, using the recurrence information, whether the malfunction has recurred after the repair or replacement. On the basis of the determination result, the instruction information generating unit determines whether to generate instruction information or whether to use generated instruction information for future repair or replacement.
摘要翻译：故障诊断信息生成装置包括维修信息取得部，其获取表示对于车辆故障进行的维修或更换的内容的修理信息或故障的原因; 故障时车辆信息获取单元，其获取指示在发生故障时检测到的车辆状态的故障时车辆信息; 指令信息生成单元，其基于修理信息和故障时间车辆信息生成可用于将来的维修或更换的指示信息; 以及重发信息获取单元，其获取指示在所述修复或更换之后所述故障是否复发的复发信息。使用复发信息确定维修或更换后故障是否复发。根据判定结果，指示信息生成部判断是否生成指示信息，或者是否使用生成的指示信息来进行将来的修理或替换。

10. 发明申请

US20100216788A1 FUSED HETEROCYCLIC COMPOUND 审中-公开
标题翻译：熔融杂环化合物
公开(公告)号：US20100216788A1
公开(公告)日：2010-08-26
申请号：US12095543
申请日：2006-12-01
申请人： Tomoyasu Ishikawa , Kazuhiro Miwa , Masaki Seto , Hiroshi Banno , Youichi Kawakita
发明人： Tomoyasu Ishikawa , Kazuhiro Miwa , Masaki Seto , Hiroshi Banno , Youichi Kawakita
IPC分类号： A61K31/5377 , C07D487/04 , A61K31/519 , C07D413/14 , A61P35/00
CPC分类号： C07D487/04
摘要： The present invention provides a compound represented by the formula: wherein R1a is a hydrogen atom, R2a is a C1-6 alkyl group substituted by a group represented by —NR6a—CO—(CH2)n—SO2— optionally halogenated C1-4 alkyl wherein n is an integer of 1 to 4, R6a is a hydrogen atom or a C1-4 alkyl group, and —(CH2)n— is optionally substituted by C1-4 alkyl, R3a is a hydrogen atom or a C1-6 alkyl group, R4a is a halogen atom or a C1-6 alkyl group, R5a is a halogen atom or a C1-6 alkyl group, and Xa is a hydrogen atom or a halogen atom, or a salt thereof. The compound of the present invention has a superior tyrosine kinase inhibitory action, is highly safe, and is sufficiently satisfactory as a pharmaceutical product.
摘要翻译：本发明提供由下式表示的化合物：其中R1a是氢原子，R2a是被-NR6a-CO-（CH2）n-SO2-代表的基团取代的C1-6烷基，任选被卤代的C 1-4烷基其中n为1〜4的整数，R6a为氢原子或C1-4烷基， - （CH2）n-为C1-4烷基，R3a为氢原子或C1-6烷基基团，R 4a是卤素原子或C 1-6烷基，R 5a是卤素原子或C 1-6烷基，X a是氢原子或卤素原子或其盐。本发明的化合物具有优异的酪氨酸激酶抑制作用，是高度安全的，并且作为药物产品足够令人满意。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式